Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co Investor Event Transcript

Nov 16, 2021 / 02:30PM GMT
Release Date Price: $59.1 (-0.87%)
Timothy Power
Bristol-Myers Squibb Company - VP & Head of IR

Well, good morning, everybody. You're very welcome to the Bristol-Myers Squibb Investor Event. I'm Tim Power from Investor Relations here at Bristol. And I just want to say it's great to see people in person for the first time in a long time. So welcome to you who are here. Welcome to everybody who's joining us online as well.

So let me just move forward, and this is our legal slide. Let me take a minute and just explain what we're going to do this morning. We're going to -- you're going to hear some presentations today from our Board Chair and Chief Executive Giovanni Caforio; you will hear from Rupert Vessey, who runs Research & Early Development here at BMS; and from Samit Hirawat, who runs late-stage development. We'll take a 10-minute break, strictly 10-minute break. I'll come back, and you'll hear from Chris Boerner, our Chief Commercialization Officer; and then from our CFO, David Elkins; and then Giovanni will close the meeting to give us plenty of time for Q&A at the end. We plan to finish the meeting around noon,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot